投稿信模版一
来源：http://forum.e2002.com/simple/index.php?t54758.html
Dear XX (Editor):
Here is our paper submitted to \The Title: XXXX
The Authors: XXX XXX and XXX
In this paper, we ...
The authors claim that none of the material in the paper has been published or is under consideration for publication elsewhere.
The corresponding author is Dr. XXX and his address and other information is as following:
Address: Department of XXX, XX University, ..., P.R.China E-mail: XXXXX@xxx.edu.cn Tel: +86-xxx-xxxxxxxx Fax: +86-xxx-xxxxxxxx
Thank you very much for consideration!
Sincerely Yours, Dr. xxx
投稿信模版二
来源：http://forum.e2002.com/simple/index.php?t48595.html
Dear Prof. XXXXX, Here within enclosed is our paper for consideration to be published on \name)\The Title: XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX The Authors: XXXXX XXXXX and XXXXX The authors claim that none of the material in the paper has been published or is under consideration for publication elsewhere. I am the corresponding author and my address and other information is as follows, Address: Department of XXXXXXXXX, Tsinghua University, Beijing, 10084, P.R.China
E-mail: XXXXX@mail.tsinghua.edu.cn Tel: 86-10-62785001 Fax: 86-10-62785001
Thank you very much for consideration!
Sincerely Yours,
Dr. XXXXXXXXXXX
投稿信模版三
来源：http://forum.e2002.com/simple/index.php?t43261.html
（1）
Dear Mr. **
1. The work described has not been submitted elsewhere for publication, in whole or in part, and all the authors listed have approved the manuscript that is enclosed.
2. I have read and have abided by the statement of ethical standards for manuscripts submitted to Neuroscience.
kind regards. Your sincerely, 通讯作者
（2）
Dear Dr. 主编name:
We submit our manuscript entitled \文章title\杂志名for publication.
接着简单介绍你文章的主要创新点和意义，不易过多，但要突出新意和关键点。 All authors have seen the manuscript and approved to submit to your journal. Thank you very much for your attention and consideration.
Sincerely yours, 通讯作者
（3）
Dear Dr. 主编name: We submit our manuscript entitled \文章title\杂志名for publication.
接着简单介绍你文章的主要创新点和意义，不易过多，但要突出新意和关键点。 All authors have seen the manuscript and approved to submit to your journal. Thank you very much for your attention and consideration.
Sincerely yours, 通讯作者
（4）Dr. ***
Editor-in-Chief, ***
(add address) January 22, 2003
Dear Dr. **,
Enclosed herewith please find 3 copies of a MS by: ?***. *** and ***? entitled: “**********”, which we would like to submit for publication in the ?******'.
Looking forward to your decision, With kind personal regards, Sincerely yours,
（5）
Dear Prof. Gil:
This is a manuscript by**and **entitled “.......”. It is submitted to be considered for publication as a “...” in your journal. This paper is new. Neither the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal.
We believe the paper may be of particular interest to the readers of your journal as it ........
Correspondence should be addressed to **at the following address, phone and fax number, and email address: ...
Thanks very much for your attention to our paper. Sincerely yours,**
投稿信模版四（实例）
来源：http://forum.e2002.com/simple/index.php?t49205.html
Case 1 Dear Editor,
We would like to submit the enclosed manuscript entitled \Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons\
GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinson’s disease.
Due to a direct competition and conflict of interest, we request that Drs. XXX of